Literature DB >> 18549260

Validation of endogenous peptide identifications using a database of tandem mass spectra.

Maria Fälth1, Marcus Svensson, Anna Nilsson, Karl Sköld, David Fenyö, Per E Andren.   

Abstract

The SwePep database is designed for endogenous peptides and mass spectrometry. It contains information about the peptides such as mass, pl, precursor protein and potential post-translational modifications. Here, we have improved and extended the SwePep database with tandem mass spectra, by adding a locally curated version of the global proteome machine database (GPMDB). In peptidomic experiment practice, many peptide sequences contain multiple tandem mass spectra with different quality. The new tandem mass spectra database in SwePep enables validation of low quality spectra using high quality tandem mass spectra. The validation is performed by comparing the fragmentation patterns of the two spectra using algorithms for calculating the correlation coefficient between the spectra. The present study is the first step in developing a tandem spectrum database for endogenous peptides that can be used for spectrum-to-spectrum identifications instead of peptide identifications using traditional protein sequence database searches.

Mesh:

Substances:

Year:  2008        PMID: 18549260     DOI: 10.1021/pr800036d

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  4 in total

1.  A mass spectrometry-based method to screen for α-amidated peptides.

Authors:  Zhenming An; Yudan Chen; John M Koomen; David J Merkler
Journal:  Proteomics       Date:  2011-12-14       Impact factor: 3.984

2.  Peptide-Spectrum Match Validation with Internal Standards (P-VIS): Internally-Controlled Validation of Mass Spectrometry-Based Peptide Identifications.

Authors:  Timothy Aaron Wiles; Laura M Saba; Thomas Delong
Journal:  J Proteome Res       Date:  2020-09-29       Impact factor: 4.466

3.  The self-peptide repertoire plays a critical role in transplant tolerance induction.

Authors:  Eric T Son; Pouya Faridi; Moumita Paul-Heng; Mario L Leong; Kieran English; Sri H Ramarathinam; Asolina Braun; Nadine L Dudek; Ian E Alexander; Leszek Lisowski; Patrick Bertolino; David G Bowen; Anthony W Purcell; Nicole A Mifsud; Alexandra F Sharland
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

4.  Most viral peptides displayed by class I MHC on infected cells are immunogenic.

Authors:  Nathan P Croft; Stewart A Smith; Jana Pickering; John Sidney; Bjoern Peters; Pouya Faridi; Matthew J Witney; Prince Sebastian; Inge E A Flesch; Sally L Heading; Alessandro Sette; Nicole L La Gruta; Anthony W Purcell; David C Tscharke
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.